The positive predictive value of asymmetrical skin creases in the diagnosis of pathological developmental dysplasia of the hip by Anderton, M.J. et al.
Article
The positive predictive value of asymmetrical skin 
creases in the diagnosis of pathological developmental 
dysplasia of the hip
Anderton, M.J., Hastie, G.R. and Paton, Robin W.
Available at http://clok.uclan.ac.uk/22602/
Anderton, M.J., Hastie, G.R. and Paton, Robin W. (2018) The positive predictive value of 
asymmetrical skin creases in the diagnosis of pathological developmental dysplasia of the hip. 
The Bone and Joint Journal, 100­B (5). pp. 675­679. ISSN 2049­4394  
It is advisable to refer to the publisher’s version if you intend to cite from the work.
http://dx.doi.org/10.1302/0301-620X.100B5.BJJ-2017-0994.R2
For more information about UCLan’s research in this area go to 
http://www.uclan.ac.uk/researchgroups/ and search for <name of research Group>.
For information about Research generally at UCLan please go to 
http://www.uclan.ac.uk/research/ 
All outputs in CLoK are protected by Intellectual Property Rights law, including
Copyright law.  Copyright, IPR and Moral Rights for the works on this site are retained 
by the individual authors and/or other copyright owners. Terms and conditions for use 
of this material are defined in the http://clok.uclan.ac.uk/policies/
CLoK
Central Lancashire online Knowledge
www.clok.uclan.ac.uk
  
Article ID BJJ-2017-0994.R2 
Article Title The positive predictive value of asymmetrical skin creases in the diagnosis of pathological 
developmental dysplasia of the hip 
Article Type Hip 
JATS Article Type  
Article Subtitle  
TOC Term Hip 
Subject Group Hip 
Keywords DDH, Developmental dysplasia of the hip, Asymmetrical skin creases 
Associated Societies  
Author Name [1] M. J. Anderton 
Author Degree(s) [1] MBChB (Hons), MRCS, FRCS(Tr&Orth) 
Author Job Title [1] Spinal Surgery Fellow 
Author Institution [1] Royal Adelaide Hospital 
Author Address [1] Port Road, Adelaide, Australia 
Author ID [1]  
Author Contribution [1] Conception of the study, Reviewing the literature, Collecting and analyzing the data, Writing, 
revising, and approving the manuscript. 
Author Name [2] G. R. Hastie 
Author Degree(s) [2] MBChB, MRCS 
Author Job Title [2] Trauma and Orthopaedic Specialist Trainee, Department of Trauma and Orthopaedics 
Author Institution [2] Royal Blackburn Teaching Hospital, East Lancashire Hospitals NHS Trust 
Author Address [2] Haslingden Road, Blackburn, UK 
Author ID [2]  
Author Contribution [2] Collecting the data, Approving the manuscript. 
Author Name [3] R. W. Paton 
Author Degree(s) [3] FRCS, FRCS (Orth), PhD, FFST 
Author Job Title [3] Consultant Orthopaedic Surgeon 
Author Institution [3] Royal Blackburn Teaching Hospital, East Lancashire Hospitals NHS Trust 
Author Address [3] Haslingden Road, Blackburn, UK and Visiting Professor, School of Medicine, University of Central 
Lancashire, Preston, UK 
Author ID [3]  
Author Contribution [3] Designing the study, Collecting and analyzing the data, Reviewing, revising, and approving the 
manuscript. 
  
Principal Institution Royal Blackburn Teaching Hospital, East Lancashire Hospitals NHS Trust, Blackburn, United Kingdom 
Correspondence Correspondence should be sent to M. J. Anderton; email: mike.anderton@doctors.org.uk 
Abstract Aims 
The aim of this study was to identify the association between asymmetrical 
skin creases of the thigh, buttock or inguinal region and pathological 
developmental dysplasia of the hip (DDH). 
Patients and Methods 
Between 1 January 1996 and 31 December 2016, all patients referred to 
our unit from primary or secondary care with risk factors for DDH were 
assessed in a “one stop” clinic. All had clinical and sonographic assessment 
by the senior author (RWP) with the results being recorded prospectively. 
The inclusion criteria for this study were babies and children referred with 
asymmetrical skin creases. Those with a neurological cause of DDH were 
excluded. The positive predictive value (PPV) for pathological DDH was 
calculated. 
Results 
A total of 105 patients met the inclusion criteria. There were 71 girls and 
34 boys. Only two were found to have pathological DDH. Both also had 
unilateral limited abduction of the hip in flexion and a positive Galeazzi 
sign with apparent leg-length discrepancy. Thus, if the specialist 
examination of a patient with asymmetrical skin creases was normal, the 
PPV for DDH was 0%. 
Conclusion 
Isolated asymmetrical skin creases are an unreliable clinical sign in the 
diagnosis of pathological DDH. Greater emphasis should be placed on the 
presence of additional clinical signs to guide radiological screening in 
babies and children. 
 
Key messages: 
- This study confirms that asymmetrical skin creases are an unreliable clinical sign in the diagnosis of 
pathological developmental dysplasia of the hip. If the hip joint is clinically normal, it is highly un-
likely there will be an association with pathological developmental dysplasia of the hip.  Routine 
radiological and sonographic imaging of the hip joints is unnecessary if there is no limitation of hip 
abduction and normal leg lengths (negative Galleazzi). Newborn and infant physical examination 
guidelines should reflect this. 
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Developmental dysplasia of the hip joint (DDH) is a dynamic condition, in which minor 
dysplasia may deteriorate to an irreducible dislocation, or an unstable hip may stabilize 
within a few weeks.[[1-6]] The abnormality may be physiological or pathological. 
Pathological DDH is defined on ultrasound as either Graf Type III or IV, or an irreducible 
dislocation. Risk factors conventionally associated with pathological DDH include female 
gender, a family history, breech presentation, oligohydramnios, postural and fixed 
deformities of the foot, caesarean section and torticollis.[[8,9]] However, recent authors have 
only identified an association with female gender, breech presentation and a family 
history.[[10-12]] Non-idiopathic instability of the hip can also occur in children with 
neuromuscular conditions and is not described as DDH.[[7]] 
In the United Kingdom, all new born babies undergo clinical assessment for 
instability of the hip with the Ortolani or Barlow manoeuvres shortly after birth, usually at 
the place of birth, and six to eight weeks later, usually within primary care. Other clinical 
signs known to have diagnostic value in pathological DDH are unilateral limitation of 
abduction of the hip in flexion[[11]] and an apparent limb length discrepancy, which can be 
seen as a short femur and a positive Galeazzi sign.[[8]] Asymmetrical skin creases can be 
defined as “asymmetry of the junction of the thigh to the trunk as viewed from the front and 
of the skin creases on the inside of the thigh".[[8]] They have been reported to be an 
important clinical sign for DDH since the 1969 Standing Medical Advisory Committee 
(SMAC) guidelines for hip screening in the United Kingdom. The more recent Newborn and 
Infant Physical Examination (NIPE) guidelines from Public Health England state that 
asymmetrical creases are a “screen positive sign" and affected children should be referred for 
expert assessment  to exclude DDH.[[12]] Experts in Europe and the United States have, 
however, questioned the association between asymmetrical skin creases and DDH in the 
  
absence of unilateral limitation of abduction of the hip in flexion.[[15-17]] The aim of this 
study was to investigate this association. 
Patients and Methods 
We established a 'one-stop' DDH screening programme in 1992. All babies referred with 
either risk factors or a clinical suspicion of DDH were assessed by the senior author (RWP) 
clinically and sonographically. Initially our catchment population included the areas of 
Blackburn, Darwen, Ribble Valley, and Hyndburn. From 2007 this expanded to include 
Burnley, Rossendale, and Pendle.  Within the clinic, the source and reason for the referral, 
the age of the child and clinical and sonographic findings were prospectively recorded in a 
database (Microsoft Excel 2016, Microsoft, Redmond, Washington), which was used to 
identify the children for this study.  
The inclusion criteria were all babies and children referred with asymmetrical skin 
creases of either the inguinal, adductor or gluteal folds between 1 January 1996 and 31 
December 2016. Exclusion criteria included neurological or syndromic aetiology. During the 
period of the study, there were 113 741 births within the catchment area and 7187 referrals to 
the clinic, of which 105 met the inclusion criteria. 
Clinical examination included the Ortolani and Barlow manoeuvres and assessment 
for unilateral limitation of abduction of the hip in flexion or apparent leg length discrepancy 
using the Galeazzi sign to examine for a short femur and assessment of leg length.[[8]] A 
normal examination was defined as a negative Ortolani and Barlow test, a full range of 
movement of the hips and equal leg lengths. The presence of asymmetrical creases were 
noted in all cases. Ultrasound imaging was performed with the baby on their side using 
modified Harcke dynamic and modified Graf static methods and a 5-7.5 MHz linear array 
transducer (Dornier AL 2200 prior to 2001, Sonosite 180 between 2001 and 2015, and 
Sonosite M Turbo from 2016).[[9,18]] A pathological hip was defined as a modified Graf 
  
type III or IV hip, as advocated by Rosendahl et al.[[18,19]] Babies aged under six months 
with a pathological hip were treated in a Pavlik harness. Those with modified Graf type II 
hips were classified as physiological and observed with serial sonography and only 
underwent treatment if the hip progressed to a modified Graf Type III or IV or to an 
irreducible dislocation. For the purpose of this study, if a Graf Type II hip progressed to a 
more severe type of dysplasia, the most severe sonographic classification was documented. 
Those with a Graf Type I hip and a normal examination were discharged. 
Statistical analysis 
The results were analysed using sensitivity and positive predictive values (PPV), calculated 
using 2 × 2 contingency tables (Microsoft Excel 2016). 
Results 
As shown in Table I, there was a trend towards increased annual referral numbers for babies 
and children with suspected DDH and asymmetrical skin creases. This was particularly 
evident after 2008, when there was also a paradoxical decline in live birth rates. 
 [[TblCap]]Table I. The total live birth rate, total number of referrals to the clinic and number 
referred with asymmetrical skin creases (ASC) between 1996 and 2016. After 1996, the 
catchment area included Blackburn, Darwen, Ribble Valley, and Hyndburn; after 2007, it 
also included Burnley, Rossendale, and Pendle 
Year Total live births Total referrals ASC referrals 
1996 3964 272 1 
1997 3767 238 0 
1998 3802 273 2 
1999 3681 235 4 
2000 3692 269 1 
2001 3605 353 1 
2002 3611 330 2 
2003 3785 269 2 
  
2004 3810 271 2 
2005 3882 274 2 
2006 3992 323 0 
2007 7292 325 2 
2008 7554 329 3 
2009 7483 320 4 
2010 7366 372 8 
2011 7280 450 9 
2012 7263 424 3 
2013 7122 461 7 
2014 7017 427 13 
2015 6839 445 21 
2016 6934 527 18 
Total 113 741 7187 105 
There were 71 girls (68%) and 34 boys (32%), of whom 94 (90%) were referred from 
primary care or community practitioners, the remainder from the new born checks. The age at 
the time of clinical assessment was bimodal in distribution, with peaks at three months and 
nine months. Apart from female gender, other recognized risk factors for DDH included one 
baby with a sibling affected by DDH and four with a breech presentation. None of these were 
diagnosed with DDH. 
The clinical and sonographic findings are shown in Tables II and III. Clinical 
examination was normal in 84 babies (80%), all of whom had Graf Type I hips on 
sonographic imaging. A further 19 (18%) were found to have another significant clinical 
finding but had normal sonographic imaging (Graf Type I). Only two (2%) had pathological 
DDH, with unilateral dislocation of the hip being diagnosed on sonography. Both were 
referred from primary care: one boy, aged three months and one girl aged ten months. Both 
had unilateral limitation of abduction of the hip in flexion and an apparent leg-length 
discrepancy with a positive Galeazzi sign. The referral letter for the girl did not record 
  
additional abnormal findings, however, the boy was also referred with an apparent leg length 
discrepancy of > 1 cm (Galeazzi positive) and decreased abduction in flexion. Both had 
otherwise normal development and no risk factors for DDH, and both were treated 
successfully with EUA, arthrogram, closed reduction and a hip spica. 
[[TblCap]]Table II. Clinical findings for developmental dysplasia of the hip (DDH) and 
associated positive predictive value (PPV) 
Clinical finding 
84 (80%) had isolated asymmetrical skin creases (ASC) (of which 0 had DDH, PPV 0%) 
19 (18%) had ASC plus one other finding (of which 0 had DDH, PPV 0%) 
8 had ASC and limited hip abduction in flexion 
11 had ASC and leg length discrepancy 
2 (2%) had ASC plus 2 other factors, both of which were confirmed to have DDH (PPV 100%) 
2 had ASC, limited abduction in flexion and a leg length discrepancy 
[[TblCap]]Table III. Results of sonographic assessment; the alpha angle was unavailable for 
one baby in the series of 105 
Alpha angle Baby’s left hip, n Baby’s right hip, n 
Graf I (> 60°) 101  100  
Graf IIa & IIb (50° to 60°) 2 - 1 had a normal clinical 
examination, discharged. baby had 
reduced abduction on initial 
examination. Reviewed at 6 mths, 
when the asymmetrical crease 
remained, but clinical examination 
was normal, thus discharged 
4 - 3 had an alpha angle of 60°; 
discharged after normal clinical 
examination. 1 had an alpha angle 
of 53° and underwent examination 
under anaesthetic, arthrography, 
closed reduction and a hip spica 
Graf IIc (43° to 49°) 0  0  
Graf III & IV (< 43°) 1 had an alpha angle of 40°; had 
an examination under anaesthetic, 
arthrogram, closed reduction and a 
hip spica 
0  
  
Thus, in babies with isolated asymmetrical skin creases, or asymmetrical creases with 
only one other clinical finding, as assessed by an experienced specialist, statistical analysis 
found a sensitivity for dislocation of the hip and a PPV both of 0%. Also, in those with 
asymmetrical creases and both limited abduction in flexion and an apparent leg-length 
discrepancy, the sensitivity and PPV were both 100% (Microsoft Excel 2016). 
Discussion 
The true prevalence of asymmetrical skin creases is unknown, although published figures 
suggest they are present in 20% to 25% of babies with normal hip joints.[[20-22]] If all 
babies found to have asymmetrical creases are referred for assessment, as the current NIPE 
guidelines suggest,[[12]] the minimum expected number of referrals to our service during the 
20-year period would have been 22 748. As we only received 105, it is probable that many 
babies were examined by experienced paediatricians and primary care professionals and 
considered to have a normal hip. However, it highlights an alarming variation in practice. 
Furthermore, of the 105 referrals, 94 (90%) were from primary care or the community, which 
suggests that asymmetrical creases are either dismissed or are not apparent in the neonatal 
population. 
When the rate of late diagnosed DDH was not reduced following the introduction of 
the Standing Medical Advisory Committee National screening programme[[13]] in 1969, one 
theory was that the examiners were poorly trained and inexperienced.[[26]] Thus in 2008, the 
United Kingdom National Screening Committee launched The National Health Service 
Newborn and Infant Physical Examination programme (NIPE),[[27]] which aimed to ensure 
that all healthcare professionals conducting examinations were fully trained and competent. It 
has been repeatedly shown that small groups of dedicated, well-trained examiners have an 
improved rate of detection of DDH, a reduction in false positive diagnosis and treatment, and 
a decrease in the rate of late diagnosis.[[23-25]] We acknowledge that there is justification 
  
for a referral if the primary healthcare professional is not confident enough to exclude DDH. 
However, individuals tasked to assess hips for DDH clinically should have the appropriate 
training to identify those hips with known risk factors, such as unilateral limitation of 
abduction of the hip in flexion or a positive Galeazzi sign. 
The NIPE 2008 guidelines paid specific attention to examination of the hips and 
stated the following: “Check symmetry of the limbs and skin folds. Perform Barlow and 
Ortolani manoeuvres”. Guidelines in the United Kingdom, including the most recent 
guidance from Public Health England for 2016 to 2017, continue to state the importance of 
assessing the symmetry of skin creases.[[8,12,27]] 
 Our study found that following the introduction of the 2008 NIPE guidelines, 
referrals for asymmetrical skin creases increased, despite a decline in live births within the 
catchment population (Table I). While it is imperative to maintain a high level of clinical 
suspicion for DDH, the evidence linking asymmetrical skin creases and DDH, in the absence 
of associated clinical findings and risk factors, remains weak. Palmen et al[[15]] studied 500 
newborns and noted that 27% had no skin creases, 40% had symmetrical creases, and 33% 
had asymmetrical creases. Four had an abnormal provocative test of hip stability, of which 
two had symmetrical creases. Barlow,[[28]] in his study of 1962, examined over 9000 infants 
and found asymmetrical creases in < 50% of those diagnosed with DDH, and the great 
majority of those with asymmetrical creases had normal hips.  
Omeroğlu and Koparal[[22]] reviewed 188 babies with suspected DDH, and found 
that the rate of DDH was 38% in those with asymetrical creases, compared with 10% in those 
without (p < 0.05). In this series five children with asymmetrical creases and abnormal 
ultrasounds had no other positive clinical finding. However, there was no mention of 
associated risk factors. Hassan and Shannak[[29]] reviewed 370 babies with confirmed DDH, 
of whom 83% had asymmetrical creases and at least one other significant clinical finding. 
  
Stein-Zamir et al[[30]] reviewed 51 babies, several of whom had more than one positive 
clinical finding, with a PPV of 50% for asymmetrical creases. While these papers all 
conclude that asymmetrical creases are an important clinical finding associated with 
DDH,[[22,29,30]] they present insufficient data to conclude that asymmetrical creases are of 
clinical significance in the absence of associated clinical findings and risk factors. 
The authors of two major systematic review articles found that it is difficult to 
conclude that asymmetrical skin creases are a useful clinical finding, there being scarce and 
unsupportive evidence linking asymmetrical creases with pathological DDH.[[17,31]] Our 
study is unique in its long period of observation and prospective data collection from one 
experienced clinician (RWP), making it more objective than previous studies. The undisputed 
clinical signs associated with pathological DDH are unilateral limitation of abduction in 
flexion after the age of two months, and a positive Galeazzi sign. If these signs were positive, 
the PPV was 100%. If a baby with asymmetrical creases has either of these clinical signs, 
radiological or sonographic assessment of the hip joint is imperative. In a baby with 
asymmetrical creases, normal movement of the hip and equal leg lengths, we found the PPV 
of DDH is 0%. This would suggest that Public Health England should review their 
guidelines, as the present recommended ‘screen positive’ guidance is not evidence-based. 
Further research in the form of a meta-analysis is warranted. 
In conclusion, this study confirms that asymmetrical skin creases are an unreliable 
clinical sign in the diagnosis of pathological DDH and that most of these babies have a 
normal hip. If the hip is clinically normal, it is highly unlikely that there will be associated 
pathological DDH. Routine radiological and sonographic imaging of the hips appears 
unnecessary if there is no limitation of abduction in flexion and normal leg lengths (negative 
Galeazzi sign). National guidelines should reflect this.  
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